RVPHW
Reviva Pharmaceuticals Holdings, Inc. - Warrants (RVPHW)
$
06About Reviva Pharmaceuticals Holdings, Inc. - Warrants (RVPHW)
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
Details
Daily high
$0.06
Daily low
$0.05
Price at open
$0.06
52 Week High
$0.78
52 Week Low
$0.02
Market cap
--
Dividend yield
0.00%
Volume
599
Avg. volume
49,564
P/E ratio
--
Reviva Pharmaceuticals Holdings, Inc. - Warrants News
Details
Daily high
$0.06
Daily low
$0.05
Price at open
$0.06
52 Week High
$0.78
52 Week Low
$0.02
Market cap
--
Dividend yield
0.00%
Volume
599
Avg. volume
49,564
P/E ratio
--